The weight-loss drug revolution exposes the weakest links in our healthcare system: drug pricing and insurance

By Los Angeles Times
| August 27, 2024

Unless the U.S. moves toward a single-payer healthcare system and starts to place limits on drug prices, it's the manufacturers of the weight-loss drugs that will reap most of the benefits.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...